The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Epigenetic-Global Market Insights and Sales Trends 2025
Synopsis
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global Epigenetic market size is expected to reach US$ 11500 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Epigenetic in various end use industries. The expanding demands from the Academic Research Institutes, Biotechnology Companies, Biopharmaceutical Companies and Diagnostic Companies, are propelling Epigenetic market. Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Kits segment is estimated at % CAGR for the next seven-year period.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Epigenetic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Epigenetic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Epigenetic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Epigenetic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Epigenetic covered in this report include Illumina, Qiagen, Abcam, Merck & Co, Sigma-Aldrich, New England Biolabs, Thermo Fisher Scientific, Diagenode and Active Motif, etc.
The global Epigenetic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis
Global Epigenetic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Epigenetic market, Segment by Type:
Reagents
Kits
Instruments
Enzymes
Services
Global Epigenetic market, by Application
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Epigenetic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Epigenetics is the study of heritable phenotype changes that do not involve alterations in the DNA sequence.
The global Epigenetic market size is expected to reach US$ 11500 million by 2029, growing at a CAGR of 7.4% from 2023 to 2029. The market is mainly driven by the significant applications of Epigenetic in various end use industries. The expanding demands from the Academic Research Institutes, Biotechnology Companies, Biopharmaceutical Companies and Diagnostic Companies, are propelling Epigenetic market. Reagents, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Kits segment is estimated at % CAGR for the next seven-year period.
The global market for epigenetic device market is expected to be driven by the advancement in technology. The key drivers of the market are the increasing cases prevalence of cancer, growing ageing population and increase in obese population.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Epigenetic, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Epigenetic market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Epigenetic market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Epigenetic sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Epigenetic covered in this report include Illumina, Qiagen, Abcam, Merck & Co, Sigma-Aldrich, New England Biolabs, Thermo Fisher Scientific, Diagenode and Active Motif, etc.
The global Epigenetic market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Illumina
Qiagen
Abcam
Merck & Co
Sigma-Aldrich
New England Biolabs
Thermo Fisher Scientific
Diagenode
Active Motif
Roche Diagnostics
Eisai
Novartis
Global Epigenetic market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Epigenetic market, Segment by Type:
Reagents
Kits
Instruments
Enzymes
Services
Global Epigenetic market, by Application
Academic Research Institutes
Biotechnology Companies
Biopharmaceutical Companies
Diagnostic Companies
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Epigenetic companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Epigenetic
1.1 Epigenetic Market Overview
1.1.1 Epigenetic Product Scope
1.1.2 Epigenetic Market Status and Outlook
1.2 Global Epigenetic Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Epigenetic Market Size by Region (2018-2029)
1.4 Global Epigenetic Historic Market Size by Region (2018-2023)
1.5 Global Epigenetic Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Epigenetic Market Size (2018-2029)
1.6.1 North America Epigenetic Market Size (2018-2029)
1.6.2 Europe Epigenetic Market Size (2018-2029)
1.6.3 Asia-Pacific Epigenetic Market Size (2018-2029)
1.6.4 Latin America Epigenetic Market Size (2018-2029)
1.6.5 Middle East & Africa Epigenetic Market Size (2018-2029)
2 Epigenetic Market by Type
2.1 Introduction
2.1.1 Reagents
2.1.2 Kits
2.1.3 Instruments
2.1.4 Enzymes
2.1.5 Services
2.2 Global Epigenetic Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Epigenetic Historic Market Size by Type (2018-2023)
2.2.2 Global Epigenetic Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Epigenetic Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Epigenetic Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Epigenetic Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Epigenetic Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Epigenetic Revenue Breakdown by Type (2018-2029)
3 Epigenetic Market Overview by Application
3.1 Introduction
3.1.1 Academic Research Institutes
3.1.2 Biotechnology Companies
3.1.3 Biopharmaceutical Companies
3.1.4 Diagnostic Companies
3.2 Global Epigenetic Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Epigenetic Historic Market Size by Application (2018-2023)
3.2.2 Global Epigenetic Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Epigenetic Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Epigenetic Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Epigenetic Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Epigenetic Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Epigenetic Revenue Breakdown by Application (2018-2029)
4 Epigenetic Competition Analysis by Players
4.1 Global Epigenetic Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Epigenetic as of 2022)
4.3 Date of Key Players Enter into Epigenetic Market
4.4 Global Top Players Epigenetic Headquarters and Area Served
4.5 Key Players Epigenetic Product Solution and Service
4.6 Competitive Status
4.6.1 Epigenetic Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Illumina
5.1.1 Illumina Profile
5.1.2 Illumina Main Business
5.1.3 Illumina Epigenetic Products, Services and Solutions
5.1.4 Illumina Epigenetic Revenue (US$ Million) & (2018-2023)
5.1.5 Illumina Recent Developments
5.2 Qiagen
5.2.1 Qiagen Profile
5.2.2 Qiagen Main Business
5.2.3 Qiagen Epigenetic Products, Services and Solutions
5.2.4 Qiagen Epigenetic Revenue (US$ Million) & (2018-2023)
5.2.5 Qiagen Recent Developments
5.3 Abcam
5.3.1 Abcam Profile
5.3.2 Abcam Main Business
5.3.3 Abcam Epigenetic Products, Services and Solutions
5.3.4 Abcam Epigenetic Revenue (US$ Million) & (2018-2023)
5.3.5 Merck & Co Recent Developments
5.4 Merck & Co
5.4.1 Merck & Co Profile
5.4.2 Merck & Co Main Business
5.4.3 Merck & Co Epigenetic Products, Services and Solutions
5.4.4 Merck & Co Epigenetic Revenue (US$ Million) & (2018-2023)
5.4.5 Merck & Co Recent Developments
5.5 Sigma-Aldrich
5.5.1 Sigma-Aldrich Profile
5.5.2 Sigma-Aldrich Main Business
5.5.3 Sigma-Aldrich Epigenetic Products, Services and Solutions
5.5.4 Sigma-Aldrich Epigenetic Revenue (US$ Million) & (2018-2023)
5.5.5 Sigma-Aldrich Recent Developments
5.6 New England Biolabs
5.6.1 New England Biolabs Profile
5.6.2 New England Biolabs Main Business
5.6.3 New England Biolabs Epigenetic Products, Services and Solutions
5.6.4 New England Biolabs Epigenetic Revenue (US$ Million) & (2018-2023)
5.6.5 New England Biolabs Recent Developments
5.7 Thermo Fisher Scientific
5.7.1 Thermo Fisher Scientific Profile
5.7.2 Thermo Fisher Scientific Main Business
5.7.3 Thermo Fisher Scientific Epigenetic Products, Services and Solutions
5.7.4 Thermo Fisher Scientific Epigenetic Revenue (US$ Million) & (2018-2023)
5.7.5 Thermo Fisher Scientific Recent Developments
5.8 Diagenode
5.8.1 Diagenode Profile
5.8.2 Diagenode Main Business
5.8.3 Diagenode Epigenetic Products, Services and Solutions
5.8.4 Diagenode Epigenetic Revenue (US$ Million) & (2018-2023)
5.8.5 Diagenode Recent Developments
5.9 Active Motif
5.9.1 Active Motif Profile
5.9.2 Active Motif Main Business
5.9.3 Active Motif Epigenetic Products, Services and Solutions
5.9.4 Active Motif Epigenetic Revenue (US$ Million) & (2018-2023)
5.9.5 Active Motif Recent Developments
5.10 Roche Diagnostics
5.10.1 Roche Diagnostics Profile
5.10.2 Roche Diagnostics Main Business
5.10.3 Roche Diagnostics Epigenetic Products, Services and Solutions
5.10.4 Roche Diagnostics Epigenetic Revenue (US$ Million) & (2018-2023)
5.10.5 Roche Diagnostics Recent Developments
5.11 Eisai
5.11.1 Eisai Profile
5.11.2 Eisai Main Business
5.11.3 Eisai Epigenetic Products, Services and Solutions
5.11.4 Eisai Epigenetic Revenue (US$ Million) & (2018-2023)
5.11.5 Eisai Recent Developments
5.12 Novartis
5.12.1 Novartis Profile
5.12.2 Novartis Main Business
5.12.3 Novartis Epigenetic Products, Services and Solutions
5.12.4 Novartis Epigenetic Revenue (US$ Million) & (2018-2023)
5.12.5 Novartis Recent Developments
6 North America
6.1 North America Epigenetic Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Epigenetic Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Epigenetic Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Epigenetic Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Epigenetic Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Epigenetic Market Dynamics
11.1 Epigenetic Industry Trends
11.2 Epigenetic Market Drivers
11.3 Epigenetic Market Challenges
11.4 Epigenetic Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
